Lilly published the results of a Phase 3b clinical trial that showed treatment with concomitant Taltz (ixekizumab) and Zepbound (tirzepatide) was superior to ixekizumab alone in patients with active psoriatic…
In this article from JDD: Excimer laser delivers measurable PASI gains but evidence is limited A JDD meta‑analysis of 308 nm excimer laser treatment for plaque psoriasis pooled four clinical…
A JDD retrospective review links generalized disease to higher comorbidity burden and reports favorable response to pentoxifylline In this article from JDD’s February 2026’s issue, authors present a single center,…
Curated by the JDD Editors Missed any of our February highlights? February is packed with intriguing articles, and you’ll want to start to dive in! Catch up with this curated…
Behind the Bottle Part Deux: A Scientific, Socratic Squawk on Sensitive and Susceptible Skin Guest: Dr. Peter Lio The JDD Podcast returns with Part 2 of "Behind the Bottle", hosted…
The JDD Podcast returns with Part 2 of “Behind the Bottle”, hosted by Dr. Adam Friedman, recorded live in front of attendees at ODAC 2026. Building on the wildly popular…
From the Vault: A JDD survey of dermatology residents highlights concerns among underrepresented groups that may influence interest in Mohs micrographic surgery and dermatologic oncology fellowships In this article from…
Check out our all-new JDD Video Abstract from Seemal R. Desai, MD who discusses Clinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation.
Practical imaging security for dermatologists: encryption, secure storage, metadata hygiene and device protocols In this Letter to the Editor published in the February issue of the Journal of Drugs in…
Watch the Latest Installment of Translational Science Lecture Series (TSLS) The field of dermatology continues to evolve at a rapid pace, bringing groundbreaking research from the lab to the clinic.…
Check Out JDD Corner’s Latest Author Spotlight Our current Author Spotlight features Aaron S. Farberg MD FAAD, one of the co-authors of “Cutaneous Adverse Events Associated With GLP-1 Receptor Agonists:…
Public health messaging misses the mark on Monkeypox and HIV A cross‑jurisdiction survey of publicly available Monkeypox and HIV materials from state, large metropolitan and select non‑metro U.S. health departments…